Current Ratio of Xeris Biopharma Holdings, Inc. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Xeris Biopharma Holdings, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • Xeris Biopharma Holdings, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 182%, a 8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Xeris Biopharma Holdings, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 182% -16% -8% 30 Sep 2025
Q2 2025 178% -21% -10% 30 Jun 2025
Q1 2025 184% -8.6% -4.5% 31 Mar 2025
Q4 2024 198% +13% +7.1% 31 Dec 2024
Q3 2024 198% -9.1% -4.4% 30 Sep 2024
Q2 2024 199% -18% -8.2% 30 Jun 2024
Q1 2024 192% -38% -16% 31 Mar 2024
Q4 2023 185% -62% -25% 31 Dec 2023
Q3 2023 207% -19% -8.5% 30 Sep 2023
Q2 2023 217% -28% -12% 30 Jun 2023
Q1 2023 230% 31 Mar 2023
Q4 2022 247% 31 Dec 2022
Q3 2022 226% 30 Sep 2022
Q2 2022 245% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.